Work

Nanoparticles crossing blood–brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions

Year: 2024

Type: editorial

Abstract: Central nervous system (CNS) diseases including depression, stroke, brain infection, brain cancer, neurodegenerations, meningitis, neuropathic pain, amyotrophic lateral sclerosis, migraine, schizop...

Source: Nanomedicine

DOI: 10.1080/17435889.2024.2380241

Authors: Julia Y Ljubimova, Eggehard Holler, Keith L Black, Alexander V Ljubimov

Institutions: Terasaki Foundation, University of Regensburg, Cedars-Sinai Medical Center, University of California, Los Angeles

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G166343535, G2590416163, Glial tumor image-guided surgery and treatment, G4318601541

OpenAlex ID: W4401398174

Cites: 20

Cited by: 6

Related to: 10